Show Summary Details
Page of

Special Considerations in the Management of Pediatric Melanoma Patients 

Special Considerations in the Management of Pediatric Melanoma Patients
Special Considerations in the Management of Pediatric Melanoma Patients

Damon Reed

and Fariba Navid

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 10 July 2020

The diagnosis and workup of melanoma in a child is often a complex process. The pathological studies, staging, surgical management, and decisions about adjuvant therapy are often based on extrapolation from adult data. At the same time, the risks and benefits of these decisions are magnified by the patient’s young age and normally long life expectancy. While the incidence of other pediatric malignancies has remained stable, the incidence of adolescent melanoma is increasing at a rate of 2% per year. In view of the multiple variables involved and the limited quantity of good prospective data, clinical decisions in pediatric melanoma are challenging.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.